MARSHALL WACE, LLP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$518,895
-87.6%
19,042
-89.9%
0.00%
-87.5%
Q2 2023$4,174,679
+57.8%
187,626
+53.6%
0.01%
+33.3%
Q1 2023$2,645,249
+251.3%
122,126
+315.8%
0.01%
+200.0%
Q3 2022$753,000
-42.4%
29,372
-46.6%
0.00%
-33.3%
Q2 2022$1,307,000
+496.8%
54,968
+452.9%
0.00%
+200.0%
Q2 2021$219,000
-80.1%
9,941
-78.5%
0.00%
-80.0%
Q1 2021$1,101,000
-83.3%
46,278
-81.6%
0.01%
-86.1%
Q4 2020$6,577,000
-31.3%
251,400
-54.3%
0.04%
-41.0%
Q3 2020$9,578,000
+49.6%
550,082
+2.1%
0.06%
-4.7%
Q1 2020$6,403,000
+873.1%
538,555
+890.4%
0.06%
+1180.0%
Q4 2019$658,000
-84.0%
54,377
-81.3%
0.01%
-84.4%
Q3 2019$4,100,000
+21.2%
290,186
-4.4%
0.03%
+14.3%
Q2 2019$3,384,000
-43.0%
303,504
-40.0%
0.03%0.0%
Q1 2019$5,940,000
-22.5%
505,962
-11.8%
0.03%
-64.1%
Q4 2018$7,667,000
+133.2%
573,836
+144.7%
0.08%
+457.1%
Q3 2018$3,288,000234,5040.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 6,911,376$155,644,0006.95%
Parallel Advisors, LLC 1,944,319$47,014,0001.86%
TANAKA CAPITAL MANAGEMENT INC 39,289$885,0001.79%
S&T BANK/PA 508,546$11,452,0001.73%
Bridge City Capital, LLC 83,967$1,891,0000.88%
Birchview Capital, LP 50,000$1,126,0000.81%
Quantedge Capital Pte Ltd 113,012$2,545,0000.75%
FAS Wealth Partners, Inc. 289,625$6,522,0000.61%
AJ WEALTH STRATEGIES, LLC 396,029$8,919,0000.44%
TRUSTCORE FINANCIAL SERVICES, LLC 208,806$4,702,0000.41%
View complete list of CORCEPT THERAPEUTICS INC shareholders